Get Alex Colville on Dwarkesh Podcast


Next goal: 5
The Case for This Conversation

General Partner at @age1vc extending healthy lifespan. PhD alum of @Thomas_Rando @stanfordmed

Dive into the cutting-edge worlds of technology and science with Dwarkesh Patel's meticulously researched interviews that bring together brilliant minds to unpack revolutionary ideas in AI, biotech, and beyond. Each episode delivers profound, thought-provoking conversations that challenge conventional wisdom and illuminate the paths shaping humanity's future.
Alex Colville just joined the board of the American Federation for Aging Research in January 2026, signaling that longevity science is moving from hype to institutions, and as general partner of age1 he is at the center of funding therapies that target aging itself. With regulators warming to healthspan endpoints after the first FDA protocol concurrence for a lifespan study in dogs in 2023, and a wave of startups racing toward human trials, his playbook for deploying capital and setting rigorous standards matters right now.
He has also been reporting on how Chinese AI models and policy are shaping global tech norms, from Uganda’s “ChatGPT for Uganda” built on Alibaba’s Qwen to shariah‑aligned NurAI with Chinese backing, a live issue that overlaps with Dwarkesh’s deep dives on AI geopolitics. To our knowledge he has not appeared on the Dwarkesh Podcast before, making this a timely first conversation that could set the agenda at the intersection of AI, biotech, and policy. Support this nomination today.
What People Are Saying
No voices yet — submit a tweet, video, or post to be the first.
Key Catalysts
Rally support from known voices who can help accelerate this nomination
Updates
No updates yet — check back as the nomination gathers momentum.
Shape What Gets Discussed
Featured Videos
Be the first to add your voice to this conversation
Record a short video telling everyone why this dialogue should happen. Your clip gets featured right here.
Nomination created on January 16, 2026





